Deva Holding (DEVA) Stock Overview
Manufactures, markets, and sells pharmaceutical products in Turkey. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
DEVA Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Join community and earn perks
Deva Holding A.S. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₺99.10 |
| 52 Week High | ₺109.30 |
| 52 Week Low | ₺57.50 |
| Beta | -0.081 |
| 1 Month Change | 16.31% |
| 3 Month Change | 40.57% |
| 1 Year Change | 48.58% |
| 3 Year Change | 12.81% |
| 5 Year Change | 360.50% |
| Change since IPO | 52,643.07% |
Recent News & Updates
Recent updates
Shareholder Returns
| DEVA | TR Pharmaceuticals | TR Market | |
|---|---|---|---|
| 7D | -3.4% | 1.0% | -8.0% |
| 1Y | 48.6% | -8.4% | 11.2% |
Return vs Industry: DEVA exceeded the TR Pharmaceuticals industry which returned -8.4% over the past year.
Return vs Market: DEVA exceeded the TR Market which returned 11.2% over the past year.
Price Volatility
| DEVA volatility | |
|---|---|
| DEVA Average Weekly Movement | 7.0% |
| Pharmaceuticals Industry Average Movement | 6.1% |
| Market Average Movement | 6.7% |
| 10% most volatile stocks in TR Market | 10.4% |
| 10% least volatile stocks in TR Market | 4.2% |
Stable Share Price: DEVA has not had significant price volatility in the past 3 months compared to the TR market.
Volatility Over Time: DEVA's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1958 | 3,057 | Philipp Haas | www.deva.com.tr |
Deva Holding A.S. manufactures, markets, and sells pharmaceutical products in Turkey. The company offers antineoplastic and immunomodulating agents; dermatological products; systemic hormanal preparations; anti-infective and antiparasitic products for systemic use; food supplements; and electrolyte solutions. It also provides products in the areas of urogenital system and sex hormones, blood and blood forming organs, cardiovascular system, musculoskeletal system, nervous system, alimentary tract and metabolism, respiratory system, urinary systems, connective tissue, and sensory organs.
Deva Holding A.S. Fundamentals Summary
| DEVA fundamental statistics | |
|---|---|
| Market cap | ₺19.98b |
| Earnings (TTM) | -₺975.75m |
| Revenue (TTM) | ₺20.17b |
Is DEVA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| DEVA income statement (TTM) | |
|---|---|
| Revenue | ₺20.17b |
| Cost of Revenue | ₺12.40b |
| Gross Profit | ₺7.78b |
| Other Expenses | ₺8.75b |
| Earnings | -₺975.75m |
Last Reported Earnings
Jun 30, 2026
Next Earnings Date
n/a
| Earnings per share (EPS) | -4.88 |
| Gross Margin | 38.54% |
| Net Profit Margin | -4.84% |
| Debt/Equity Ratio | 18.3% |
How did DEVA perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/09/18 18:36 |
| End of Day Share Price | 2026/09/18 00:00 |
| Earnings | 2026/06/30 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Deva Holding A.S. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.